Drug intelligence / Profile preview

3-methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole

Development stage
Unknown
Modality
Small Molecules
01

Overview

**3-Methyl–5-(7-{4-[ (4R)–4-methyl–4,5-dihydro–1,3–oxazol–2‑yl ]phenoxy }heptyl )‑1,2‑oxazole** is a synthetic small molecule belonging to the phenol ethers chemical class. It features an oxazole and oxazoline moiety connected via a heptyl linker to a phenoxy group. The compound is listed in several chemical and drug databases (PubChem CID: 5272139; DrugBank ID: DB08727; ChEMBL ID: CHEMBL55483). It is described as experimental with no approved medical indications or clinical trials reported. Its only known molecular target is the "genome polyprotein," suggesting it may have been investigated for antiviral activity or as a research tool targeting viral polyproteins[1][6][2]. No pharmacological mechanism of action or therapeutic use has been established.

Other names
98524–87–9CHEMBL55483CHEMBL-55483CHEMBL 55483DB08727DB-08727DB 08727DTXSID00243632DTXSID-00243632DTXSID 00243632

Beyond the preview

Go deeper on 3-methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call